IL-Iβ+3954 C/T Polymorphism and Its Clinical Associations in Egyptian Sickle Cell Disease Patients

Rasha Abdel-Raouf Abdel-Aziz Afifi1, Yasser Mohamad Sedky1, Hesham Abd-ELKareem2

  • 1Department of Pediatrics, Cairo University, Cairo, Egypt.

Insights

The study found a higher prevalence of a specific Interleukin-1 beta (IL-1β) gene variant in Egyptian sickle cell disease (SCD) patients. This variant was linked to increased pulmonary hypertension risk in SCD patients.

Area of Science:

  • Genetics
  • Hematology
  • Immunology

Background:

  • Sickle cell disease (SCD) is an inherited hemolytic anemia causing chronic inflammation and reduced quality of life.
  • Interleukin-1 beta (IL-1β) plays a role in inflammatory diseases, and its single nucleotide polymorphisms (SNPs) may predict disease prognosis.
  • IL-1β (+3954C/T) SNP is investigated for its potential role in modifying SCD phenotypes.

Purpose of the Study:

  • To investigate the IL-1β (+3954C/T) single nucleotide polymorphism (SNP) as a potential genetic modifier in sickle cell disease (SCD).
  • To explore the association between IL-1β (+3954C/T) SNP and clinical and laboratory features of SCD patients.

Main Methods:

  • A cross-sectional study involving 50 SCD patients and 50 healthy controls.
  • Genotyping of IL-1β (+3954C/T) SNP using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
  • Analysis of associations between the IL-1β (+3954C/T) SNP and SCD clinical and laboratory profiles.

Main Results:

  • The homozygous mutant genotype (TT) for IL-1β (+3954C/T) SNP was significantly more prevalent in SCD patients (26%) compared to controls (6%).
  • The TT genotype was associated with significantly higher mean pulmonary arterial pressure (42.62 mmHg) in SCD patients compared to CC and CT genotypes (33.49 mmHg).

Conclusions:

  • An increased prevalence of the IL-1β +3954 SNP mutant genotype was observed in Egyptian SCD patients.
  • The IL-1β +3954 SNP mutant genotype was more common in SCD patients with pulmonary hypertension, suggesting a role in disease complications.
  • These findings indicate a potential role for IL-1β +3954 SNP in the pathophysiology and manifestations of sickle cell disease.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
590
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
757
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
345
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
527
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
379
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K